Search results
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Zacks via Yahoo Finance· 2 years agoEli Lilly LLY and partner Incyte INCY announced that the FDA has granted approval to their oral JAK...
Nature's answer to JAK3 inhibition: Discovering five herbal and natural alternatives
The Gainesville Sun via Yahoo News· 6 months agoJAK3 inhibitors have become a buzzword in pharmaceuticals, with significant implications for...
My Top Value Stock to Buy In 2023
Motley Fool· 1 year agoThe past three years have been significant for pharma giant Pfizer (NYSE: PFE) and its shareholders. For instance, Pfizer's shares remain reasonably...
Pfizer's (PFE) Q3 Loss Narrows, Sales Miss on COVID Slump
Zacks via Yahoo Finance· 6 months agoPfizer PFE reported third-quarter 2023 adjusted loss per share of 17 cents, which was narrower than...
Pfizer's (PFE) Etrasimod Filings Receive Review Acceptance
Zacks via Yahoo Finance· 1 year agoThe regulatory filings seek approval for Pfizer's (PFE) etrasimod in UC indication. A final decision...
Pfizer (PFE) to Report Q2 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 10 months agoHigher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like...
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think
Motley Fool· 9 months agoPfizer (NYSE: PFE) reported a 53% year-over-year decline in revenue in its latest quarter. There's...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks via Yahoo Finance· 2 weeks agoPfizer PFE reported first-quarter 2024 adjusted earnings per share of 82 cents, which comfortably...
Pfizer's (PFE) Key Drugs to Drive Q3 Earnings Amid COVID Decline?
Zacks via Yahoo Finance· 6 months agoPfizer (PFE) expects better non-COVID operational revenue growth sequentially in the third quarter,...
Pfizer (PFE) Q4 Earnings Top, Revenues Miss on COVID Sales Slump
Zacks via Yahoo Finance· 3 months agoPfizer PFE reported fourth-quarter 2023 adjusted earnings per share of 10 cents in contrast to the...
